Abstract:The current work aims to take full advantage of the structural superiority and hepatoprotective effect of nutriment trans-p-coumaric acid (TPCA) to decrease the solubility and dissolution rate of antimycotic agent 5-fluorocytosine (FLCY) by co-crystallization strategie, thereby giving a novel understanding into conquering dose-limiting hepatotoxicity induced by quick and almost complete absorption of FLCY. Toward that end, FLCY-TPCA, as the first cocrystal of FLCY with phenolic acid nutriment of hydroxycinnamic acid types, is orientationally self-assembled and fully characterized. The single crystal structure identifies that TPCA molecules in the crystal lattice capture the polar sites in situ of FLCY via robust hydrogen bond interplays, thus creating a vital planar construction (VPC) possessing hydrophobe feature, which results in the simultaneous down-regulation for the cocrystal in solubility and dissolution rate versus parent FLCY. The outcomes of the experiment are forcefully supported by related theory researches. Molecular electrostatic potential (MEP) calculation manifests that the VPC polarity in the cocrystal is lower than that of free FLCY, which conforms with the reduction in polarity due to intensifying hydrogen-bonds energy based on topology analysis with atoms in molecules (AIM) theory, hence conferring a conspicuous improvement in hydrophobicity on the cocrystal. Furthermore, the molecular planarity analysis on account of Multiwfn's wave function calculation module confirms the convergence in planarity at a two-dimensional infinite level, which undoubtedly contributes to accomplishing a tight three-dimensional supramolecular superposition landscape, corresponding with the coinstantaneous reinforcement of π-π stacking interaction analyzed by the reduced density gradient (RDG), and all these further support the fact that the hydrophobicity of FLCY-TPCA cocrystal is significantly enhanced. As a result, the current contribution exemplifies the feasible cocrystallization clues by integrated experimental with systematic theoretical approaches to overcoming intractable toxicity issues of antifungal agents.

Elucidating of Fluconazole Cocrystallization With a Cutting-Edge Nutraceutical Coformer for Enhanced Formulation Strategies

Novel Potentially Antifungal Hybrids of 5-Flucytosine and Fluconazole: Design, Synthesis and Bioactive Evaluation.

From Formulation Design for Bioavailability Improvement to Biocompatibility Testing and Antifungal Efficacy Evaluation

Enhancing Stability and Formulation Capability of Fungicides by Cocrystallization Through a Novel Multistep Slurry Conversion Process

Design, Preparation, Characterization and Evaluation of Five Cocrystal Hydrates of Fluconazole with Hydroxybenzoic Acids

Pharmaceutical Cocrystals: A Novel Systematic Approach for the Administration of Existing Drugs in New Crystalline Form

Cocrystallization with nutrient ferulic acid towards reducing the dissolubility behaviors of antifungal drug 5-fluorocytosine: An integrated theoretical and experimental case research

Self-assembly of antifungal agent 5-fluorocytosine and nutrient trans-p-coumaric acid furnishes a cocrystallization clue with the potential to reduce toxicity and side effects for the drug: a case research of combining theory with experiment

Optimizing fluconazole-embedded transfersomal gel for enhanced antifungal activity and compatibility studies

Simultaneous Improvement of Dissolution Behavior and Oral Bioavailability of Antifungal Miconazole via Cocrystal and Salt Formation

Simultaneous Enhancement of Thermal Stability and Preferred Isomer Enrichment in Difenoconazole: the Dual Facets of Cocrystal Engineering

Fluconazole Microemulsions: Preparation, Statistical Optimization by Two-Level Factorial Design, and Physicochemical Evaluation

Self-assembly of Antifungal Agent 5-Fluorocytosine and Nutrient Trans-P-coumaric Acid Furnishes a Cocrystal with the Potential to Reduce Toxicity and Side Effects for the Drug: a Case Study Combining Theory with Experiment

Novel Polymorphic Cocrystals of the Non-Steroidal Anti-Inflammatory Drug Niflumic Acid: Expanding the Pharmaceutical Landscape

Structural Elucidation and Release Enhancement of the Florfenicol/β-Cyclodextrin Inclusion Complex

Formulation and evaluation of Fluconazole Nanosuspensions: In vitro characterization and transcorneal permeability studies

Supramolecular self-assembly with p-coumaric acid offers the first cocrystal for perfecting the physicochemical peculiarity and enhancing antifungal effect of drug bifonazole

Preparation, characterization and evaluation of fenofibrate: benzoic acid cocrystals with enhanced pharmaceutical properties

Development of cream to enhance the antifungal activity and reduce the side effects of fluconazole for the treatment of Candida albicans

Using the Cocrystal Approach as a Promising Drug Delivery System to Enhance the Dissolution and Bioavailability of Formononetin Using an Imidazole Coformer

Variable stoichiometry and a salt–cocrystal intermediate in multicomponent systems of flucytosine: structural elucidation and their impact on stability